Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis.
Beuselinck B, Lerut E, Wolter P, Dumez H, Berkers J, Van Poppel H, Joniau S, Oyen R, De Wever L, Strijbos M, Paridaens R, Schöffski P. Beuselinck B, et al. Among authors: de wever l. Clin Genitourin Cancer. 2014 Oct;12(5):e205-14. doi: 10.1016/j.clgc.2014.04.004. Epub 2014 May 9. Clin Genitourin Cancer. 2014. PMID: 24861951
Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation.
Beulque Y, Deleu AL, Punie K, De Wever L, Baldewijns M, Caruso S, Couchy G, Zucman-Rossi J, Beuselinck B. Beulque Y, et al. Among authors: de wever l. Clin Genitourin Cancer. 2019 Oct;17(5):e909-e912. doi: 10.1016/j.clgc.2019.06.013. Epub 2019 Jul 11. Clin Genitourin Cancer. 2019. PMID: 31378579 No abstract available.
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
Draulans C, Everaerts W, Isebaert S, Van Bruwaene S, Gevaert T, Oyen R, Joniau S, Lerut E, De Wever L, Laenen A, Weynand B, Defraene G, Vanhoutte E, De Meerleer G, Haustermans K. Draulans C, et al. Among authors: de wever l, de meerleer g. J Urol. 2020 Apr;203(4):713-718. doi: 10.1097/JU.0000000000000652. Epub 2019 Nov 13. J Urol. 2020. PMID: 31718396
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors.
Beuselinck B, Pans S, Bielen J, De Wever L, Noppe N, Vanderschueren G, De Keyzer F, Baldewijns M, Lerut E, Laenen A, Verbiest A, Roussel E, Albersen M, Vandecaveye V. Beuselinck B, et al. Among authors: de wever l, de keyzer f. Acta Oncol. 2020 Jul;59(7):818-824. doi: 10.1080/0284186X.2020.1750696. Epub 2020 Apr 16. Acta Oncol. 2020. PMID: 32297532
Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.
Ahmadi Bidakhvidi N, Laenen A, Jentjens S, Deroose CM, Van Laere K, De Wever L, Mai C, Berghen C, De Meerleer G, Haustermans K, Joniau S, Everaerts W, Goffin K. Ahmadi Bidakhvidi N, et al. Among authors: de wever l, de meerleer g. EJNMMI Res. 2021 Apr 30;11(1):41. doi: 10.1186/s13550-021-00783-w. EJNMMI Res. 2021. PMID: 33929626 Free PMC article.
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials.
Roussel E, Verbiest A, Kinget L, Boeckx B, Zucman-Rossi J, Couchy G, Caruso S, Job S, de Reyniès A, De Wever L, Baldewijns M, Van Poppel H, Joniau S, Lambrechts D, Albersen M, Beuselinck B. Roussel E, et al. Among authors: de wever l. Clin Genitourin Cancer. 2021 Dec;19(6):e382-e394. doi: 10.1016/j.clgc.2021.07.005. Epub 2021 Jul 10. Clin Genitourin Cancer. 2021. PMID: 34362692
40 results